Corvus Pharmaceuticals In... (CRVS)
Corvus Pharmaceuticals Max Pain By Strike
CRVS trades at $5.22, 4.4% above the near-term max pain of $5 expiring Sep 19, 2025 (31 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($3-$5), reflecting growing call interest at higher strikes. Key magnetic zone at 4 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Corvus Pharmaceuticals Max Pain By Expiry
Max pain for CRVS shows an upward trend from 3 to 5, suggesting bullish positioning in longer-dated options. The 50% spread signals divergent expectations across timeframes. Most levels below 5.22 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 5 | -0.22 (-4.31%) |
| Oct 17, 2025 | 4 | -1.22 (-23.44%) |
| Jan 16, 2026 | 4 | -1.22 (-23.44%) |
| Apr 17, 2026 | 3 | -2.22 (-42.58%) |